SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹30 Cr | ₹20 Cr | ₹9.63 Cr | ₹8.23 Cr | ₹18 Cr |
What is the latest Short Term Loans and Advances ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹9.63 Cr |
| Mar2022 | ₹8.23 Cr |
| Mar2017 | ₹18 Cr |
How is Short Term Loans and Advances of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 53.89 | |
| Mar2024 | ₹20 Cr | 103.46 | |
| Mar2023 | ₹9.63 Cr | 16.97 | |
| Mar2022 | ₹8.23 Cr | -53.05 | |
| Mar2017 | ₹18 Cr | - | |
Compare Short Term Loans and Advances of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,283.1 Cr | -6.1% | 3.3% | -8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -6.1% |
3.3% |
-8.6% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses